Understanding Autoantibody Screening Tests: Methods, Interpretation, and Analysis Practicalities

Opinion
Video

Schafer Boeder, MD and Andrea Stallings, PA delve into the intricacies of autoantibody screening tests for T1D with detailed insights on their methodologies, interpretation nuances, and practical analysis considerations.

Recent Videos
New Research Amplifies Impact of Social Determinants of Health on Cardiometabolic Measures Over Time
Where Should SGLT-2 Inhibitor Therapy Begin? Thoughts from Drs Mikhail Kosiborod and Neil Skolnik
Related Content
First-Ever Guideline Establishes Lifestyle Intervention as Central Strategy in Treating and Reversing Type 2 Diabetes and Prediabetes / image credit ©American College of Lifestyle Medicine

First-Ever Guideline Establishes Lifestyle Intervention as Central Strategy in Treating, Reversing Type 2 Diabetes and Prediabetes

Grace Halsey
June 11th 2025
Article

Novel guidelines include specific strategies that support the prescription, implementation, and monitoring of lifestyle changes to reach glycemic control and, possibly, disease remission.

Obesity & Type 2 Diabetes: An Expert Discussion

Obesity & Type 2 Diabetes: An Expert Discussion

Sydney Jennings
June 30th 2023
Podcast

In our latest episode, 2 obesity experts discuss the importance of early intervention to reduce risk for complications, suggestions for managing patients in primary care, and more.

Investigational GPR119 Agonist Shows Dual Hepatoprotective and Glycemic Benefits in MASH Patients / image credit ©Wowow/stock.adobe.com

Investigational GPR119 Agonist Shows Dual Hepatoprotective and Glycemic Benefits in MASH Patients

Grace Halsey
May 7th 2025
Article

EASL 2025. DA-1241 significantly reduced plasma ALT levels, improved systemic inflammatory and fibrosis biomarkers, according to drug developer MetaVia.

Episode 17: Kidney Outcomes with Tirzepatide in Type 2 Diabetes

Episode 17: Kidney Outcomes with Tirzepatide in Type 2 Diabetes

Sydney Jennings
July 22nd 2022
Podcast

"Primary Viewpoints," a podcast from Patient Care Online, brings you an exclusive interview with Hiddo Heerspink, PhD, PharmD.

Dexcom G7 15 Day CGM System Cleared by FDA / image credit ©Waldenmarus/stock.adobe.com

Dexcom G7 15 Day CGM System Cleared by FDA

Grace Halsey
April 10th 2025
Article

The extended wear benefit is augmented by the G7 15 Day CGM system's superior evidence-based accuracy, with a MARD of 8.0%

Omnipod 5 System Leads to Significant Glycemic Improvements After Direct Transition from MDI Insulin Plus CGM

Omnipod 5 System Leads to Significant Glycemic Improvements After Direct Transition from MDI Insulin with CGM

Grace Halsey
March 27th 2025
Article

Mean reduction in HbA1c was nearly 1% after transition from MDI plus CGM to Omnipod 5 in the first randomized trial to evaluate the shift in mode of insulin delivery.

© 2025 MJH Life Sciences

All rights reserved.